Drug Pipeline

Panitumumab-IRDye800 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
5
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 1/2
4
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT03510208 Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery Malignant Brain Neoplasm Recruiting
NCT03582124 Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Lung Carcinoma Recruiting
NCT03384238 Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery Pancreatic Adenocarcinoma Recruiting
NCT04085887 Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures Brain Tumor Recruiting
Early Phase 1
NCT06819228 Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck… HNSCC Recruiting
NCT07493447 Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect… Meningioma Not Yet Recruiting
Sponsors Running Panitumumab-IRDye800 Trials
Disease Areas
Get alerts when Panitumumab-IRDye800 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free